Healthcare - Biotechnology - NASDAQ - US
$ 9.26
-6.75 %
$ 1.08 B
Market Cap
-5.54
P/E
Price Target
Average
58.39%
Revenue Forecast
Estimate
89.96%
EBIT
Estimate
27.51%
Net Income
Estimate
27.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Arcutis Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ARQT of $14.7 , with forecasts ranging from a low of $8 to a high of $18 .
ARQT Lowest Price Target
Wall Street Target
8 USD
-13.61%
ARQT Average Price Target
Wall Street Target
14.7 USD
58.39%
ARQT Highest Price Target
Wall Street Target
18 USD
94.38%
REVENUE FORECAST
Revenue Forecast Chart ARQT
EBIT FORECAST
EBIT Forecast Chart ARQT
NET INCOME FORECAST
Net Income Chart ARQT